Literature DB >> 20970851

Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo.

Hui Xie1, Yanhong Zhu, Weili Jiang, Qing Zhou, Hai Yang, Ning Gu, Yu Zhang, Huibi Xu, Haibo Xu, Xiangliang Yang.   

Abstract

A specific contrast agent for magnetic resonance imaging (MRI) is crucial to brain tumor patients for the surgical operation or the postoperative radiology. This study explored lactoferrin-conjugated superparamagnetic iron oxide nanoparticles (Lf-SPIONs) as an MRI contrast agent for the detection of brain gliomas in vivo. The hydrodynamic diameter of about 75 nm, saturation magnetization of 51 emu/g Fe and T(2) relaxivity of 75.6 mM(-1)S(-1) of the Lf-SPIONs suggested its applicability for MRI. Using a rat model of C6 glioma, Lf-SPIONs provided a better picture or more sensitivity to depict brain glioma on MR images than that of SPIONs. Significantly enhanced T(2)-weighted images of brain glioma were documented in vivo with Lf-SPIONs until 48 h after injection. Moreover, Lf-SPIONs were clearly observed around vascular region of the tumor slices after 48 h. High level expression of Lf receptors was confirmed in brain tumor tissues by RT-PCR and Western Blot compared to normal brain tissues. These findings suggested that Lf-SPIONs could be potentially employed as a sensitive and specific MRI contrast agent in the diagnosis of brain glioma.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20970851     DOI: 10.1016/j.biomaterials.2010.09.024

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  31 in total

Review 1.  Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer.

Authors:  Liangqian Tong; Ming Zhao; Shu Zhu; Jing Chen
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

2.  Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma.

Authors:  Shanshan Wang; Sören Reinhard; Chengyi Li; Min Qian; Huiling Jiang; Yilin Du; Ulrich Lächelt; Weiyue Lu; Ernst Wagner; Rongqin Huang
Journal:  Mol Ther       Date:  2017-05-11       Impact factor: 11.454

3.  Fabrication of magnetic nanochains linked with CTX and curcumin for dual modal imaging detection and limitation of early tumour.

Authors:  Yuedi Yang; Zhongbing Huang; Ximing Pu; Guangfu Yin; Lei Wang; Fabao Gao
Journal:  Cell Prolif       Date:  2018-08-21       Impact factor: 6.831

Review 4.  Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.

Authors:  Raziye Mohammadpour; Marina A Dobrovolskaia; Darwin L Cheney; Khaled F Greish; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2019-07-08       Impact factor: 15.470

5.  Advanced Functional Nanomaterials for Theranostics.

Authors:  Haoyuan Huang; Jonathan F Lovell
Journal:  Adv Funct Mater       Date:  2016-11-07       Impact factor: 18.808

Review 6.  Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.

Authors:  Forrest M Kievit; Miqin Zhang
Journal:  Adv Mater       Date:  2011-08-15       Impact factor: 30.849

Review 7.  Nanoparticles for imaging and treating brain cancer.

Authors:  Joseph D Meyers; Tennyson Doane; Clemens Burda; James P Basilion
Journal:  Nanomedicine (Lond)       Date:  2013-01       Impact factor: 5.307

Review 8.  Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation.

Authors:  Kruti S Soni; Swapnil S Desale; Tatiana K Bronich
Journal:  J Control Release       Date:  2015-11-10       Impact factor: 9.776

9.  Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging.

Authors:  Asahi Tomitaka; Hamed Arami; Sonu Gandhi; Kannan M Krishnan
Journal:  Nanoscale       Date:  2015-10-28       Impact factor: 7.790

Review 10.  Therapeutic nanomedicine for brain cancer.

Authors:  Stephany Y Tzeng; Jordan J Green
Journal:  Ther Deliv       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.